22 November 2017
News and Views
Links and Services
Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome, reports this month's issue of the Diseases of the Colon & Rectum.
Complete pathological response has proven prognostic benefits in patients with locally advanced r
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors